nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—KCNJ8—Inwardly rectifying K+ channels—KCNJ4—Parkinson's disease	0.0891	0.0904	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—VIM—Parkinson's disease	0.0618	0.0628	CbGpPWpGaD
Levosimendan—KCNJ8—Potassium Channels—HCN3—Parkinson's disease	0.0546	0.0554	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—VIM—Parkinson's disease	0.0525	0.0533	CbGpPWpGaD
Levosimendan—KCNJ11—Inwardly rectifying K+ channels—KCNJ4—Parkinson's disease	0.0422	0.0428	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—VIM—Parkinson's disease	0.0415	0.0421	CbGpPWpGaD
Levosimendan—KCNJ8—Potassium Channels—KCNJ4—Parkinson's disease	0.0352	0.0357	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.0338	0.0343	CbGpPWpGaD
Levosimendan—KCNJ11—Potassium Channels—HCN3—Parkinson's disease	0.0259	0.0262	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.0256	0.026	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—INSR—Parkinson's disease	0.025	0.0254	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—HCN3—Parkinson's disease	0.0238	0.0242	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—TALDO1—Parkinson's disease	0.0177	0.018	CbGpPWpGaD
Levosimendan—KCNJ11—Potassium Channels—KCNJ4—Parkinson's disease	0.0167	0.0169	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.016	0.0162	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—KCNJ4—Parkinson's disease	0.0154	0.0156	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—DLG1—Parkinson's disease	0.0133	0.0135	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—HCN3—Parkinson's disease	0.0113	0.0115	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.0108	0.0109	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—GRIK1—Parkinson's disease	0.0104	0.0105	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.0104	0.0105	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.0102	0.0104	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00892	0.00905	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—GRIK2—Parkinson's disease	0.00882	0.00895	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—SLC18A2—Parkinson's disease	0.00854	0.00867	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—ADORA2A—Parkinson's disease	0.00766	0.00778	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—MAPK8—Parkinson's disease	0.00757	0.00768	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00753	0.00764	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—KCNJ4—Parkinson's disease	0.00727	0.00738	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00727	0.00737	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—CHRNA4—Parkinson's disease	0.00676	0.00686	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00645	0.00654	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—DRD1—Parkinson's disease	0.00642	0.00652	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—Parkinson's disease	0.00635	0.00645	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—DLG1—Parkinson's disease	0.00628	0.00637	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—HSPA8—Parkinson's disease	0.0062	0.00629	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00614	0.00623	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—TNF—Parkinson's disease	0.00599	0.00608	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—DOCK3—Parkinson's disease	0.00599	0.00608	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MERTK—Parkinson's disease	0.00599	0.00608	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—DLG4—Parkinson's disease	0.00582	0.0059	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—GRIN2B—Parkinson's disease	0.00568	0.00577	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—HTR7—Parkinson's disease	0.00562	0.00571	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—SLC6A3—Parkinson's disease	0.0056	0.00569	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—DGKQ—Parkinson's disease	0.00534	0.00542	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—GRIK1—Parkinson's disease	0.00491	0.00499	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—COMT—Parkinson's disease	0.00476	0.00483	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—MAOA—Parkinson's disease	0.00473	0.0048	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—GRIK2—Parkinson's disease	0.00418	0.00424	CbGpPWpGaD
Levosimendan—KCNJ11—Regulation of insulin secretion—INS—Parkinson's disease	0.00406	0.00412	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—SLC18A2—Parkinson's disease	0.00405	0.00411	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00364	0.00369	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00363	0.00368	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MAG—Parkinson's disease	0.00344	0.00349	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00337	0.00342	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CHRNA4—Parkinson's disease	0.0032	0.00325	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—INS—Parkinson's disease	0.00319	0.00324	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GPR37—Parkinson's disease	0.00306	0.00311	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—DGKQ—Parkinson's disease	0.00306	0.00311	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—HSPA8—Parkinson's disease	0.00293	0.00298	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.0028	0.00284	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—DLG4—Parkinson's disease	0.00275	0.0028	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—GRIN2B—Parkinson's disease	0.00269	0.00273	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—SLC6A3—Parkinson's disease	0.00265	0.00269	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00264	0.00268	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GRK5—Parkinson's disease	0.00256	0.0026	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GRK5—Parkinson's disease	0.00232	0.00236	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GRM4—Parkinson's disease	0.00229	0.00233	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—COMT—Parkinson's disease	0.00226	0.00229	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—MAOA—Parkinson's disease	0.00224	0.00227	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VPS35—Parkinson's disease	0.00218	0.00222	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PENK—Parkinson's disease	0.00217	0.00221	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—FGB—Parkinson's disease	0.00217	0.0022	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MCCC1—Parkinson's disease	0.00215	0.00219	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ND3—Parkinson's disease	0.00215	0.00219	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.00213	0.00216	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GRM4—Parkinson's disease	0.00208	0.00211	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TALDO1—Parkinson's disease	0.00203	0.00206	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—OMD—Parkinson's disease	0.00203	0.00206	CbGpPWpGaD
Levosimendan—TNNC1—cardiovascular system—Parkinson's disease	0.00202	0.137	CbGeAlD
Levosimendan—PDE3A—GPCR downstream signaling—PDYN—Parkinson's disease	0.00199	0.00202	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PENK—Parkinson's disease	0.00197	0.002	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NDUFB11—Parkinson's disease	0.00192	0.00195	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GRM5—Parkinson's disease	0.00185	0.00188	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GCH1—Parkinson's disease	0.00183	0.00186	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GPR37—Parkinson's disease	0.00181	0.00184	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DGKQ—Parkinson's disease	0.00181	0.00184	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PDYN—Parkinson's disease	0.00181	0.00183	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GRM5—Parkinson's disease	0.00168	0.0017	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00166	0.00168	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GBA—Parkinson's disease	0.00163	0.00166	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—FBP1—Parkinson's disease	0.00163	0.00166	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—DBH—Parkinson's disease	0.00163	0.00166	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SOD1—Parkinson's disease	0.00161	0.00163	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00157	0.0016	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ABL1—Parkinson's disease	0.00154	0.00156	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF2—Parkinson's disease	0.00153	0.00155	CbGpPWpGaD
Levosimendan—KCNJ8—cardiovascular system—Parkinson's disease	0.00152	0.103	CbGeAlD
Levosimendan—PDE3A—Signaling Pathways—RIT2—Parkinson's disease	0.00145	0.00147	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HGF—Parkinson's disease	0.00144	0.00147	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00143	0.00145	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRK5—Parkinson's disease	0.00137	0.00139	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00136	0.00138	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—TAC1—Parkinson's disease	0.00134	0.00136	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—DRD1—Parkinson's disease	0.00132	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—DRD3—Parkinson's disease	0.00128	0.00129	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HTR1A—Parkinson's disease	0.00124	0.00126	CbGpPWpGaD
Levosimendan—KCNJ11—cardiovascular system—Parkinson's disease	0.00123	0.0838	CbGeAlD
Levosimendan—PDE3A—Signaling Pathways—GRM4—Parkinson's disease	0.00123	0.00125	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—TAC1—Parkinson's disease	0.00122	0.00124	CbGpPWpGaD
Levosimendan—PDE3A—cardiovascular system—Parkinson's disease	0.00121	0.0821	CbGeAlD
Levosimendan—KCNJ11—Metabolism—DDC—Parkinson's disease	0.0012	0.00122	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—DRD1—Parkinson's disease	0.0012	0.00121	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00119	0.00121	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PENK—Parkinson's disease	0.00117	0.00118	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAG—Parkinson's disease	0.00117	0.00118	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—DRD3—Parkinson's disease	0.00116	0.00118	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—DRD2—Parkinson's disease	0.00115	0.00117	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—HTR7—Parkinson's disease	0.00115	0.00117	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA4—Parkinson's disease	0.00113	0.00115	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00108	0.0011	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDYN—Parkinson's disease	0.00107	0.00108	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—DRD2—Parkinson's disease	0.00105	0.00106	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HTR7—Parkinson's disease	0.00105	0.00106	CbGpPWpGaD
Levosimendan—KCNJ8—head—Parkinson's disease	0.00103	0.0697	CbGeAlD
Levosimendan—KCNJ11—Metabolism—PLA2G6—Parkinson's disease	0.00102	0.00103	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MAOB—Parkinson's disease	0.00101	0.00102	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GFAP—Parkinson's disease	0.001	0.00102	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRM5—Parkinson's disease	0.000992	0.00101	CbGpPWpGaD
Levosimendan—KCNJ8—nervous system—Parkinson's disease	0.000973	0.066	CbGeAlD
Levosimendan—KCNJ8—central nervous system—Parkinson's disease	0.000937	0.0636	CbGeAlD
Levosimendan—PDE3A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000924	0.000937	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF20—Parkinson's disease	0.00087	0.000883	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000843	0.000856	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EDN1—Parkinson's disease	0.000839	0.000851	CbGpPWpGaD
Levosimendan—KCNJ11—head—Parkinson's disease	0.000836	0.0568	CbGeAlD
Levosimendan—PDE3A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000808	0.00082	CbGpPWpGaD
Levosimendan—KCNJ11—nervous system—Parkinson's disease	0.000793	0.0538	CbGeAlD
Levosimendan—PDE3A—Signaling Pathways—INSR—Parkinson's disease	0.000778	0.00079	CbGpPWpGaD
Levosimendan—KCNJ11—central nervous system—Parkinson's disease	0.000763	0.0518	CbGeAlD
Levosimendan—KCNJ11—Metabolism—CYP2D6—Parkinson's disease	0.000749	0.000761	CbGpPWpGaD
Levosimendan—KCNJ11—cerebellum—Parkinson's disease	0.000746	0.0506	CbGeAlD
Levosimendan—KCNJ8—brain—Parkinson's disease	0.000744	0.0505	CbGeAlD
Levosimendan—KCNJ11—Metabolism—CTGF—Parkinson's disease	0.000736	0.000747	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGB—Parkinson's disease	0.000735	0.000746	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000734	0.000745	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HTR1A—Parkinson's disease	0.000732	0.000743	CbGpPWpGaD
Levosimendan—PDE3A—cerebellum—Parkinson's disease	0.000731	0.0496	CbGeAlD
Levosimendan—PDE3A—Signaling Pathways—TAC1—Parkinson's disease	0.000721	0.000731	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DRD1—Parkinson's disease	0.000707	0.000717	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2E1—Parkinson's disease	0.000685	0.000696	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DRD3—Parkinson's disease	0.000684	0.000695	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NQO1—Parkinson's disease	0.000678	0.000688	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TH—Parkinson's disease	0.000668	0.000678	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYCS—Parkinson's disease	0.000641	0.000651	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000639	0.000649	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HTR7—Parkinson's disease	0.000619	0.000628	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DRD2—Parkinson's disease	0.000619	0.000628	CbGpPWpGaD
Levosimendan—KCNJ11—brain—Parkinson's disease	0.000606	0.0411	CbGeAlD
Levosimendan—PDE3A—brain—Parkinson's disease	0.000594	0.0403	CbGeAlD
Levosimendan—KCNJ11—Metabolism—COMT—Parkinson's disease	0.000568	0.000576	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTP1—Parkinson's disease	0.000565	0.000574	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MAOA—Parkinson's disease	0.000564	0.000572	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMOX1—Parkinson's disease	0.000558	0.000566	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCB1—Parkinson's disease	0.000535	0.000543	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTM1—Parkinson's disease	0.00052	0.000527	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF2—Parkinson's disease	0.000519	0.000526	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1R—Parkinson's disease	0.000501	0.000509	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPX1—Parkinson's disease	0.000497	0.000505	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EDN1—Parkinson's disease	0.000496	0.000503	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTHFR—Parkinson's disease	0.000459	0.000466	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NGF—Parkinson's disease	0.000455	0.000462	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HTR2A—Parkinson's disease	0.000433	0.00044	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOE—Parkinson's disease	0.000427	0.000434	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOE—Parkinson's disease	0.000403	0.000409	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—INS—Parkinson's disease	0.000365	0.000371	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—INS—Parkinson's disease	0.000344	0.000349	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—Parkinson's disease	0.000256	0.00026	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—Parkinson's disease	0.000255	0.000258	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK8—Parkinson's disease	0.000236	0.000239	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—Parkinson's disease	0.00015	0.000153	CbGpPWpGaD
